Proximal Ventures raises debut fund to back startups bringing AI to drug development (opens techcrunch.com)
Former SignalFire investor Sahir Raoof's first fund targets AI in pharma.
Context: Baba builds AI tools that help Medicare and Medicaid patients connect to care teams and handle advocacy tasks; FirstMark led the round.
From fiercehealthcare.com: Baba, which develops AI tools to help Medicare and Medicaid patients connect to care teams and handle advocacy tasks, raised a $40M Series A led by FirstMark — Applied artificial intelligence company Baba secured $40 million in series A funding to modernize the Medicare and Medicaid experience.
Baba · Series A · $40M · with FirstMarkAs stated by fiercehealthcare.com.
Former SignalFire investor Sahir Raoof's first fund targets AI in pharma.
Oura buys Counsel Health for $625M weeks after postponing its own IPO; Oura added Counsel's AI chatbot to its app earlier this year.
We help the labs behind your medicines deliver study results 10x faster.
The Alphabet-owned AI drug discovery company would raise roughly $5B at about a $50B valuation, after a $2.1B round in May.
Opentrons will use the money to scale its lab robotics, software and data infrastructure.